Chia Health Library
Editorial standards and medical review
Our goal is useful, current patient education with clear sourcing and honest accountability—especially when evidence is early, treatment is compounded, or regulation is changing.
Who creates Chia articles
The Chia Health Editorial Team is accountable for articles carrying the organizational byline. Writers and editors may use research and drafting tools, including AI assistance. We do not assign a clinician’s name or credentials unless that clinician explicitly reviewed and signed off on the article.
How we use evidence
Medical claims should trace to accessible sources. We prioritize current FDA materials, official public-health guidance, systematic reviews, peer-reviewed human studies, and registered clinical trials. Animal, cell, observational, and early-stage findings are labeled so they are not mistaken for proven patient outcomes.
How we discuss treatments
Educational content is not individual medical advice. We distinguish FDA-approved indications from off-label, compounded, and investigational uses; include material safety limits; and describe Chia treatments only when they appear in our current public catalog. Eligibility and prescribing always require an individual evaluation by a licensed clinician.
AI assistance and human accountability
AI tools may help organize research, draft explanations, or identify questions patients ask. Before publication, the editorial workflow checks source use, clarity, treatment information, internal links, regulatory framing, and known compliance risks. Automation never substitutes for named clinical sign-off.
Updates and corrections
Time-sensitive medical and regulatory information is reviewed against current primary sources. Material corrections update the visible modification date. If you see an error or a source that no longer supports a claim, contact support@chia.health with the article URL and the passage in question.
Commercial transparency
Chia is a telehealth clinic, and some articles discuss treatments Chia offers. Commercial relevance does not change the evidence standard: articles must identify uncertainty, avoid guarantees, and explain that a prescription is never assured.